This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Verty, A. N. A. Articles by Mallet, P. E. Search for Related Content PubMed PubMed Citation Articles by Verty, A. N. A. Articles by Mallet, P. E. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH

Evidence for an Interaction between CB₁ Cannabinoid and Melanocortin MCR-4 Receptors in Regulating Food Intake

Schools of Psychology (A.N.A.V., P.E.M.) and Biological, Biomedical and Molecular Science (J.R.M.), University of New England, Armidale, New South Wales 2351; and School of Psychology (I.S.M.), University of Sydney, New South Wales 2006, Australia

Address all correspondence and requests for reprints to: Dr. Paul Mallet, School of Psychology, University of New England, Armidale, New South Wales 2351, Australia. E-mail: paul.mallet{at}une.edu.au.

Melanocortin receptor 4 (MCR4) and CB₁ cannabinoid receptors independently modulate food intake. Although an interaction between the cannabinoid and melanocortin systems has been found in recovery from hemorrhagic shock, the interaction between these systems in modulating food intake has not yet been examined. The present study had two primary purposes: 1) to examine whether the cannabinoid and melanocortin systems act independently or synergistically in suppressing food intake; and 2) to determine the relative position of the CB₁ receptors in the chain of control of food intake in relation to the melanocortin system. Rats were habituated to the test environment and injection procedure and then received intracerebroventicular injections of various combinations of the MCR4 receptor antagonist JKC-363, the CB₁ receptor agonist ⁹-tetrahydrocannabinol, the MCR4 receptor agonist -MSH, or the cannabinoid CB₁ receptor antagonist SR 141716. Food intake and locomotor activity were then recorded for 120 min. When administrated alone, SR 141716 and -MSH dose-dependently attenuated baseline feeding, whereas sub-anorectic doses of SR 141716 and -MSH synergistically attenuated baseline feeding when combined. ⁹-Tetrahydrocannabinol-induced feeding was not blocked by -MSH, whereas SR 141716 dose-dependently attenuated JKC-363-induced feeding. Locomotor activity was not significantly affected by any drug treatment, suggesting that the observed effects on feeding were not due to a nonspecific reduction in motivated behavior. These findings revealed a synergistic interaction between the cannabinoid and melanocortin systems in feeding behavior. These results further suggested that CB₁ receptors are located downstream from melanocortin receptors and CB₁ receptor signaling is necessary to prevent the melanocortin system from altering food intake.

This article has been cited by other articles:

				H. Butler and M. Korbonits Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists Eur. J. Endocrinol., November 1, 2009; 161(5): 655 - 662. [Abstract] [Full Text] [PDF]

				B. Guesdon, E. Paradis, P. Samson, and D. Richard Effects of intracerebroventricular and intra-accumbens melanin-concentrating hormone agonism on food intake and energy expenditure Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2009; 296(3): R469 - R475. [Abstract] [Full Text] [PDF]

				R. Nogueiras, C. Veyrat-Durebex, P. M. Suchanek, M. Klein, J. Tschop, C. Caldwell, S. C. Woods, G. Wittmann, M. Watanabe, Z. Liposits, et al. Peripheral, but Not Central, CB1 Antagonism Provides Food Intake-Independent Metabolic Benefits in Diet-Induced Obese Rats Diabetes, November 1, 2008; 57(11): 2977 - 2991. [Abstract] [Full Text] [PDF]

				C. Doyon, R. G. Denis, E.-D. Baraboi, P. Samson, J. Lalonde, Y. Deshaies, and D. Richard Effects of Rimonabant (SR141716) on Fasting-Induced Hypothalamic-Pituitary-Adrenal Axis and Neuronal Activation in Lean and Obese Zucker Rats Diabetes, December 1, 2006; 55(12): 3403 - 3410. [Abstract] [Full Text] [PDF]

				P. Pacher, S. Batkai, and G. Kunos The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462. [Abstract] [Full Text] [PDF]

				K. M. Gadde and D. B. Allison Cannabinoid-1 Receptor Antagonist, Rimonabant, for Management of Obesity and Related Risks Circulation, August 29, 2006; 114(9): 974 - 984. [Full Text] [PDF]

				U. Pagotto, G. Marsicano, D. Cota, B. Lutz, and R. Pasquali The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance Endocr. Rev., February 1, 2006; 27(1): 73 - 100. [Abstract] [Full Text] [PDF]

				S. Stanley, K. Wynne, B. McGowan, and S. Bloom Hormonal Regulation of Food Intake Physiol Rev, October 1, 2005; 85(4): 1131 - 1158. [Abstract] [Full Text] [PDF]

				I. S. McGREGOR, K. D. B. DAM, P. E. MALLET, and J. E. GALLATE {Delta}9-THC REINSTATES BEER- AND SUCROSE-SEEKING BEHAVIOUR IN ABSTINENT RATS: COMPARISON WITH MIDAZOLAM, FOOD DEPRIVATION AND PREDATOR ODOUR Alcohol Alcohol., January 1, 2005; 40(1): 35 - 45. [Abstract] [Full Text] [PDF]